Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 4,015.00
-205.00 (-4.86%)
At close: Oct 22, 2026
| Market Cap | 209.98B +153.9% |
| Revenue (ttm) | 24.46B +1.8% |
| Net Income | -41.36B |
| EPS | -1,180.23 |
| Shares Out | 52.30M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 318,024 |
| Open | 4,225.00 |
| Previous Close | 4,220.00 |
| Day's Range | 3,970.00 - 4,225.00 |
| 52-Week Range | 2,615.00 - 10,180.00 |
| Beta | 0.28 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |